Advanced in Myhre Syndrome

Kathleen M. Claes

Gent, VLG, BE 
Advanced in Myhre Syndrome
Gent, VLG, BE 
OverviewLocationsClinical Research

Overview

Kathleen Claes practices in Gent, Belgium. Ms. Claes is rated as an Advanced expert by MediFind in the treatment of Myhre Syndrome. Her top areas of expertise are End-Stage Renal Disease (ESRD), Neurofibromatosis, Seckel Syndrome, Kidney Transplant, and Parathyroidectomy.

Her clinical research consists of co-authoring 198 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Myhre Syndrome.

Gender
Female

Locations

Gent, VLG 9000, Belgium
Other Locations
Leuven, VLG, Belgium
Brussels, BRU, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
Investigator-Steered Project on Intravascular Renal Denervation for Management of Drug-Resistant Hypertension
Investigator-Steered Project on Intravascular Renal Denervation for Management of Drug-Resistant Hypertension
Enrollment Status: Completed
Publish Date: March 27, 2020
Intervention Type: Procedure
Study Phase: Not Applicable
View 1 Less Clinical Trial

198 Total Publications

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Journal: Nature communications
Published: September 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Claes's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 58 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile